Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 23, 2024

Primary Completion Date

June 11, 2025

Study Completion Date

June 11, 2025

Conditions
Pain Measurement
Interventions
COMBINATION_PRODUCT

Analgesia Nociception Index, remimazolam

"The purpose of this study is to determine the validity of ANI in patients undergoing surgery with remifentanil and remimazolam.~During this study, remimazolam infusion rate is determined by the pharmacopoeia.~Remifentanil infusion rate is determined based on the patient's vital signs, systemic status and pain levels. And remifentanil is administrated via targeted infusion control using the Minto model.~ANI scores, vital signs, remifentanil infusion rate are collected at predetermined time points according to the protocol from the start to the end of the surgery."

Trial Locations (1)

22711

RECRUITING

Catholic-Kwandong University, School of Medicine, Incheon

All Listed Sponsors
lead

Catholic Kwandong University

OTHER